Transforming the treatment of antibiotic-resistant infections with next-generation immunotherapies to improve patient outcomes worldwide.
San Diego, CA
Joined November 2017
- Tweets2
- Following49
- Followers20
- Likes1
Today we welcome three key opinion leaders to our advisory board: Patrick Vink, M.D., MBA, William Boyle, Ph.D., and Richard Proctor, M.D.
telephusbio.com/#news
#osteomyelitis #MRSA #antiinfective
Telephus medical founder awarded $6 Million NIH grant to expand translational research in #MRSA-related bone infections bit.ly/2mBJ73l
#osteomyelitis
